ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.214,79
-0,51%
S&P 500
5.827,04
-1,54%
Dow Jones
41.938,45
-1,63%
Euro vs US Dollar
1,02545
-0,01%
Bitcoin
94.153,55
-0,58%
Pepperstone
Advertisement
Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Tenax Therapeutics Inc (TENX)

  7. Tenax Therapeutics Inc (TENX) News

TENX

Tenax Therapeutics (TENX)

Tenax Therapeutics Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:TENX
DatumZeitQuelleÜberschriftSymbolFirma
10/01/202522h27Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202402h09Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202402h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202402h04Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202402h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202401h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202401h54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
13/12/202401h49Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
06/12/202422h54Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TENXTenax Therapeutics Inc
05/12/202419h47Edgar (US Regulatory)Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
04/12/202423h16Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
26/11/202422h30Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TENXTenax Therapeutics Inc
15/11/202401h14Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
14/11/202418h39Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
14/11/202418h21Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
13/11/202423h35Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:TENXTenax Therapeutics Inc
13/11/202422h04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TENXTenax Therapeutics Inc
13/11/202414h15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
12/11/202415h32Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
31/10/202421h05GlobeNewswire Inc.Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation ConferenceNASDAQ:TENXTenax Therapeutics Inc
30/10/202421h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TENXTenax Therapeutics Inc
27/09/202414h14Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:TENXTenax Therapeutics Inc
13/09/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:TENXTenax Therapeutics Inc
12/09/202422h15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:TENXTenax Therapeutics Inc
10/09/202423h19Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
30/08/202422h20Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TENXTenax Therapeutics Inc
30/08/202422h19Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:TENXTenax Therapeutics Inc
23/08/202422h31Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:TENXTenax Therapeutics Inc
20/08/202400h48Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
19/08/202422h15Edgar (US Regulatory)Form SC 13G - Statement of Beneficial Ownership by Certain InvestorsNASDAQ:TENXTenax Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:TENX

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
CCOM
US100
US Tech 100
USOTC
DTEGY
Deutsche Telekom (QX)
COIN
ADAUSD
Cardano
NYSE
KO
Coca Cola
TG
CBK
Commerzbank
TG
MBG
MercedesBenz
COIN
XRPUSD
Ripple
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
TG
BAS
BASF
TG
DTE
Deutsche Telekom
FX
EURJPY
Euro vs Yen
TG
ALV
Allianz
USOTC
BNPQY
BNP Paribas (QX)
DBI
SDXP
SDAX
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten